Titrate: Increase by roughly 0.5 mg every four weeks as tolerated
25.2 months for the PIONEER 6 and SUSTAIN-6 trials, respectively) [35,36], the HR of the PIONEER 6 study may have been statistically significant if the follow-up duration had been longer
So, while were monitoring for any potential issues, theres also a chance your liver health could see some benefits
Decisions about using GLP-1 medicines after breast cancer should involve multidisciplinary input from your GP, oncologist, and potentially an endocrinologist or diabetes specialist, particularly if you have a history of thyroid disease
Bacterial contamination accelerates peptide degradation and could theoretically cause infection, though the sublingual vehicle itself often contains antimicrobial properties
Causes Stressful Life Events Surgery Significant Weight Loss Hormonal Changes Certain Medications Treatment Telogen Effluvium is typically reversible once the stressor stops